Maine AG Secures Insulin Price Cap Settlement
Maine AG Aaron Frey announced a settlement with Sanofi-Aventis U.S. LLC to resolve allegations that the pharmaceutical company’s deceptive pricing policies resulted in underinsured and uninsured patients having to pay higher list prices for insulin. According to the AG’s office, Sanofi will cap out-of-pocket insulin costs at $35 per month for Maine consumers through 2029. …